These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 25295906
1. Ophthalmologic findings in hepatitis C patients treated with pegylated interferon α-2b and ribavirin. Novelli FJ, Przysiezny A, Rosa EL, Garcia RF, Nóbrega MJ. Arq Bras Oftalmol; 2014; 77(3):178-81. PubMed ID: 25295906 [Abstract] [Full Text] [Related]
3. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin. Fouad YM, Khalaf H, Ibraheem H, Rady H, Helmy AK. Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957 [Abstract] [Full Text] [Related]
7. [Retinopathy in a patient with hepatitis C treated with pegylated interferon and ribavirin: case report]. Avila MP, Freitas AM, Isaac DL, Bastos AL, Pena RV. Arq Bras Oftalmol; 2006 Jan; 69(2):255-9. PubMed ID: 16699680 [Abstract] [Full Text] [Related]
8. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C. Okuse C, Yotsuyanagi H, Nagase Y, Kobayashi Y, Yasuda K, Koike K, Iino S, Suzuki M, Itoh F. World J Gastroenterol; 2006 Jun 21; 12(23):3756-9. PubMed ID: 16773695 [Abstract] [Full Text] [Related]
10. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes? Mousa N, Besheer T, Gad Y, Elbendary A, Mokbel T, Abdel-Aziz A. J Ocul Pharmacol Ther; 2013 Apr 21; 29(3):345-8. PubMed ID: 23113644 [Abstract] [Full Text] [Related]
12. Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C. Adams S, Ostermeier M. Optometry; 2010 Nov 21; 81(11):580-6. PubMed ID: 20655283 [Abstract] [Full Text] [Related]
13. Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening. Vujosevic S, Tempesta D, Noventa F, Midena E, Sebastiani G. Hepatology; 2012 Aug 21; 56(2):455-63. PubMed ID: 22331668 [Abstract] [Full Text] [Related]
16. [Retinopathy during interferon treatment in combination with ribavirin for chronic hepatitis C]. Nakamura T, Takahashi H, Koike N, Mitsutaka M, Soda M, Kimu M. Nippon Ganka Gakkai Zasshi; 2005 Nov 21; 109(11):748-52. PubMed ID: 16363669 [Abstract] [Full Text] [Related]
18. Retinal thrombosis secondary to the combination therapy of pegylated interferon and ribavirin for chronic hepatitis C virus infection. A rare complication. Ortega-Ibarra FS, Remes-Troche JM. Rev Esp Enferm Dig; 2013 Nov 21; 105(5):291-2. PubMed ID: 23971660 [No Abstract] [Full Text] [Related]
19. Hepatitis C: a review of diagnosis, management, and ocular complications from treatment. Tsolakos A, Zalatimo N. Optometry; 2003 Aug 21; 74(8):517-23. PubMed ID: 12926825 [Abstract] [Full Text] [Related]
20. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin. Serranti D, Indolfi G, Nebbia G, Cananzi M, D'Antiga L, Ricci S, Stagi S, Azzari C, Resti M, Italian Study Group for Treatment of Chronic Hepatitis C in Children. Pediatr Infect Dis J; 2018 Apr 21; 37(4):287-291. PubMed ID: 28953189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]